ArticleRenal failure2025
Multimodal deep learning improving the accuracy of pathological diagnoses for membranous nephropathy.
Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial intelligence-powered renal pathology for glomerular disease classification: a systematic review and meta-analysis.Renal failure · 2026Pooled it
- Risk prediction in IgA nephropathy: from conventional models to machine learning, deep learning, and precision nephrology.Renal failure · 2026Review
- Artificial intelligence in genitourinary pathology.Histopathology · 2026Review
- The lipid-podocyte axis: emerging clues in membranous nephropathy pathogenesis.Frontiers in medicine · 2026Review
- Artificial Intelligence in Nephrology: From Early Detection to Clinical Management of Kidney Diseases.Bioengineering (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesRenal biopsy is the gold standard for the diagnosis of glomerular diseases including membranous nephropathy (MN), however, it faces challenges in accuracy, objectivity, and reproducibility of tissue evaluation. This study aims to develop a multimodal pathological diagnosis system to assist pathologists in diagnosing MN in morphology.
methodsUsing PASM-stained, immunofluorescence, and electron microscopy images from MN patients, we built three deep-learning models to detect lesions. The outputs of these models were combined to provide a comprehensive pathological diagnosis. Our system was compared with pathologists, validated on external test sets, and detected in 138 patients with various kidney diseases.
resultsConsidering PASM-stained images, our model had a classification accuracy of 91.74%, a recall of 81.97%, and an F1 score of 86.58% for spike identification. For immunofluorescence images, our model had an accuracy rate of 98.97%, a recall rate of 99.65%, and an F1 score of 99.31% for MN classification. Regarding the segmentation of electron-dense deposits, the segmentation model had a Dice coefficient of 85.66% and an IoU of 75.93%. Our model presented superior performance to that of pathologists in fluorescence image classification and segmentation of deposits, achieved high accuracy in spike identification and fluorescence image classification in external test sets, and could be targeted to diagnose MN in a wide range of glomerular diseases.
conclusionsThis multimodal pathological diagnosis system can not only assist pathologists in diagnosing MN rapidly and accurately but also lays the foundation to develop diagnostic models for other glomerular diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.